Clinical trial
Study of Bleeding With Extended Administration of an Oral Contraceptive
NCT00338052 · Warner Chilcott, Industry · Completed
Key facts
| NCT number | NCT00338052 |
|---|---|
| Title | Study of Bleeding With Extended Administration of an Oral Contraceptive |
| Official title | Open-Label Study of Cycle Control With Extended Administration of Norethindrone Acetate 1 mg / Ethinyl Estradiol 20 Mcg Oral Tablets |
| Lead sponsor | Warner Chilcott, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Contraception |
| Intervention type | Drug |
| Interventions | Norethindrone 1 mg / ethinyl estradiol 20 mcg |
| Enrollment | 207 |
| Start date | Jun 1, 2006 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Jun 20, 2006 |
| Last update posted | May 8, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: